Overview
Aleksandar Stojic practices practicing medicine in Heidelberg, Germany.
Mr. Stojic is highly rated in 1 condition, according to our data. His clinical expertise encompasses Optic Neuritis, CACH Syndrome, and Multiple Sclerosis (MS).
He is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Aleksandar Stojic
Is Aleksandar Stojic a top-rated expert for Optic Neuritis?
MediFind is an objective health platform that identifies experts based on real-world data. Aleksandar Stojic is classified as an Advanced expert for Optic Neuritis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Aleksandar Stojic participate in research or clinical trials?
Yes. Aleksandar Stojic has published 9 articles and abstracts on conditions like Optic Neuritis. You can view a list of Aleksandar Stojic's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Optic NeuritisMr. Stojic isAdvanced. Learn about Optic Neuritis.
- Experienced
- CACH SyndromeMr. Stojic isExperienced. Learn about CACH Syndrome.
- Multiple Sclerosis (MS)Mr. Stojic isExperienced. Learn about Multiple Sclerosis (MS).